JCRB1330 Ty-82
Cell information
Important Notice(s)Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1330 | Cell Name | Ty-82 |
---|---|---|---|
Profile | Thymic carcinoma cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 22 |
Identity | available | Tissue for Primary Cancer | thymus |
Case history | Undifferentiated thymic carcinoma | Metastasis | |
Tissue Metastasized | Genetics | 46XX,t(15;19)(q15;p13). | |
Life Span | infinite | Crisis PDL | |
Morphology | anaplastic carcinoma cell | Character | Thymic carcinoma. |
Classify | tumor | Established by | Kubonishi,I. |
Registered by | Miyoshi,I. | Regulation for Distribution | |
Comment | Year | 2007 | |
Medium | RPMI 1640 medium with 20% fetal calf serum | Methods for Passages | dilution |
Cell Number on Passage | Split ratio = 1/2 - 1/3 | Race | Japanese |
CO2 Conc. | 5% | Tissue Sampling | pleural effusion |
Tissue Type | anaplastic carcinoma cell |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:1730520 | Establishment and characterization of a thymic carcinoma cell line (Ty-82) carrying t(15;19)(q15;p13) chromosome abnormality. Kuzume T,Kubonishi I,Takeuchi S,Takeuchi T,Iwata J,Sonobe H,Ohtsuki Y,Miyoshi I Int J Cancer. 1992 Jan 21;50(2):259-64 |
Images |
---|
LOT Information
Cell No. | JCRB1330 | Cell Name | |
---|---|---|---|
LOT No. | 02152010 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS, GIBCO Cat. # 10099). | Temperature | 37 C |
Cell Density at Seeding | 1.3 - 3.9 x 10^5 cells/ml | Methods for Passages | Dilution |
Doubling Time | approx. 30 hrs | Cell Number in Vial (cells/1ml) | 2.3 x 10^5 |
Viability at cell freezing (%) | 84.3 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1330 | Cell Name | Ty-82 |
---|---|---|---|
LOT No. | 02232009 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(Hyclone GRD0051) | Temperature | 37 C |
Cell Density at Seeding | 3.3x10^5 cells/ml | Methods for Passages | 1/2-1/13 |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 3.6x10^6 |
Viability at cell freezing (%) | 95.1 | Antibiotics Used | free |
Passage Number | p6* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,11 D13S317:11 D7S820:12,13 D16S539:9,11 VWA:17,19 TH01:6,9.3 AM:X TPOX:9,11 CSF1PO:11,12 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1330 | Cell Name | Ty-82 |
---|---|---|---|
LOT No. | 09082016 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 1.9 - 4.3 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Split ratio = 1/2 - 1/3 is recommended. |
Doubling Time | approx. 53 hrs. | Cell Number in Vial (cells/1ml) | 3.3 x 10^6 |
Viability at cell freezing (%) | 85 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 85 | Additional information |
Cell No. | JCRB1330 | Cell Name | Ty-82 |
---|---|---|---|
LOT No. | 03162022 | Lot Specification | distribution |
Medium | RPMI 1640 medium with heat-inactivated fetal bovine serum (FBS; Biowest Cat. # S1820-500) | Temperature | 37 C |
Cell Density at Seeding | 0.5 - 3.2 x 10^5 cells/mL | Methods for Passages | Although this cell line is described as suspension culture, sometimes cells will attach to dish. In such case, please use trypsin treatment for harvesting cells. |
Doubling Time | 55 - 82 hrs. | Cell Number in Vial (cells/1ml) | 3.9 x 10^6 |
Viability at cell freezing (%) | 81.7 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Y/N | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 80.0 | Additional information |